{"id":46039,"date":"2022-07-11T19:01:50","date_gmt":"2022-07-11T17:01:50","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/"},"modified":"2022-07-11T19:01:50","modified_gmt":"2022-07-11T17:01:50","slug":"global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/","title":{"rendered":"Global Melanoma Therapeutics Market (2022 to 2027) &#8211; Featuring AB Sciences, AbbVie and Genentech Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5601759\/global-melanoma-therapeutics-market-2022-2027?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=v9s2dk&amp;utm_campaign=1724438+-+Global+Melanoma+Therapeutics+Market+(2022+to+2027)+-+Featuring+AB+Sciences%2C+AbbVie+and+Genentech+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Melanoma Therapeutics Market (2022-2027) by Type of Melanoma, Therapy, Diagnostics, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220711005741\/en\/1509779\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220711005741\/en\/1509779\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe Global Melanoma Therapeutics Market is estimated to be USD 12.06 Bn in 2022 and is projected to reach USD 19.79 Bn by 2027, growing at a CAGR of 10.41%.\n<\/p>\n<p>\nMarket dynamics are forces that impact the prices and behaviors of the Global Melanoma Therapeutics Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.\n<\/p>\n<p>\nAs the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.\n<\/p>\n<p>\n<strong>Competitive Quadrant<\/strong>\n<\/p>\n<p>\nThe report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.\n<\/p>\n<p>\n<strong>Ansoff Analysis<\/strong>\n<\/p>\n<ul>\n<li>\nThe report presents a detailed Ansoff matrix analysis for the Global Melanoma Therapeutics Market. Ansoff Matrix, also known as Product\/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.\n<\/li>\n<li>\nThe report analyses the Global Melanoma Therapeutics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.\n<\/li>\n<li>\nBased on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.\n<\/li>\n<\/ul>\n<p>\n<strong>Why buy this report?<\/strong>\n<\/p>\n<ul>\n<li>\nThe report offers a comprehensive evaluation of the Global Melanoma Therapeutics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.\n<\/li>\n<li>\nThe report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.\n<\/li>\n<li>\nThe report includes an in-depth market analysis using Porter&#8217;s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.\n<\/li>\n<li>\nThe report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.\n<\/li>\n<li>\nThe report also contains the competitive analysis using Positioning Quadrants, the analyst&#8217;s Proprietary competitive positioning tool.\n<\/li>\n<\/ul>\n<p>\n<strong>Market Dynamics<\/strong>\n<\/p>\n<p>\n<strong><em>Drivers<\/em><\/strong>\n<\/p>\n<ul>\n<li>\nIncreasing Prevalence of Melanoma Cases\n<\/li>\n<li>\nIncrease in Need for Cost-Effective Therapeutics in Developing Regions\n<\/li>\n<\/ul>\n<p>\n<strong><em>Restraints<\/em><\/strong>\n<\/p>\n<ul>\n<li>\nLack of Innovative and Successful Therapies\n<\/li>\n<\/ul>\n<p>\n<strong><em>Opportunities<\/em><\/strong>\n<\/p>\n<ul>\n<li>\nSurge in Demand for Targeted Therapy Owing to Reduced Side Effects and Higher Efficiency\n<\/li>\n<li>\nOngoing Research and Development Activities to Introduce Effective Drugs\n<\/li>\n<\/ul>\n<p>\n<strong><em>Challenges<\/em><\/strong>\n<\/p>\n<ul>\n<li>\nStringent Regulatory Policies and Lengthy Approval Process\n<\/li>\n<\/ul>\n<p>\n<strong>Market Segmentations<\/strong>\n<\/p>\n<p>\nThe Global Melanoma Therapeutics Market is segmented based on Type of Melanoma, Therapy, Diagnostics, and Geography.\n<\/p>\n<ul>\n<li>\nBy Type of Melanoma, the market is classified into Acral Lentiginous Melanoma, Lentigo Maligna Melanoma, Nodular Melanoma, and Superficial Spreading Melanoma.\n<\/li>\n<li>\nBy Therapy, the market is classified into Chemotherapy, Immunotherapy, Targeted Therapy, and Radiation Therapy.\n<\/li>\n<li>\nBy Diagnostics, the market is classified into Dermatoscopy Devices, Bipsy and Biopsy Devices.\n<\/li>\n<li>\nBy Geography, the market is classified into Americas, Europe, Middle-East &amp; Africa and Asia-Pacific.\n<\/li>\n<\/ul>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAB Sciences\n<\/li>\n<li>\nAbbVie\n<\/li>\n<li>\nAmgen\n<\/li>\n<li>\nAptose Biosciences\n<\/li>\n<li>\nAstraZeneca\n<\/li>\n<li>\nBristol-Myers Squibb\n<\/li>\n<li>\nCK Life Sciences Int&#8217;l\n<\/li>\n<li>\nDaiichi Sankyo\n<\/li>\n<li>\nEli Lilly\n<\/li>\n<li>\nGenentech\n<\/li>\n<li>\nJohnson &amp; Johnson\n<\/li>\n<li>\nMerck\n<\/li>\n<li>\nNovartis\n<\/li>\n<li>\nONO Pharmaceutical\n<\/li>\n<li>\nPhilogen\n<\/li>\n<li>\nPierre Fabre\n<\/li>\n<li>\nPolynoma\n<\/li>\n<li>\nProvectus\n<\/li>\n<li>\nRoche\n<\/li>\n<li>\nSanofi\n<\/li>\n<li>\nTakeda Pharmaceutical\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5601759\/global-melanoma-therapeutics-market-2022-2027?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=v9s2dk&amp;utm_campaign=1724438+-+Global+Melanoma+Therapeutics+Market+(2022+to+2027)+-+Featuring+AB+Sciences%2C+AbbVie+and+Genentech+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/t34snx<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x70;&#114;&#x65;&#115;&#x73;&#64;&#x72;e&#x73;e&#x61;r&#x63;h&#x61;n&#100;&#x6d;&#97;&#x72;&#107;&#x65;&#116;&#x73;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#114;e&#x73;&#115;&#64;&#x72;&#x65;&#115;e&#x61;&#114;c&#x68;&#x61;&#110;d&#x6d;&#97;r&#x6b;&#x65;&#116;s&#x2e;&#99;o&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Melanoma Therapeutics Market (2022-2027) by Type of Melanoma, Therapy, Diagnostics, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Melanoma Therapeutics Market is estimated to be USD 12.06 Bn in 2022 and is projected to reach USD 19.79 Bn by 2027, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46039","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Melanoma Therapeutics Market (2022 to 2027) - Featuring AB Sciences, AbbVie and Genentech Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Melanoma Therapeutics Market (2022 to 2027) - Featuring AB Sciences, AbbVie and Genentech Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Melanoma Therapeutics Market (2022-2027) by Type of Melanoma, Therapy, Diagnostics, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Melanoma Therapeutics Market is estimated to be USD 12.06 Bn in 2022 and is projected to reach USD 19.79 Bn by 2027, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-11T17:01:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220711005741\/en\/1509779\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Melanoma Therapeutics Market (2022 to 2027) &#8211; Featuring AB Sciences, AbbVie and Genentech Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-11T17:01:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\\\/\"},\"wordCount\":752,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005741\\\/en\\\/1509779\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\\\/\",\"name\":\"Global Melanoma Therapeutics Market (2022 to 2027) - Featuring AB Sciences, AbbVie and Genentech Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005741\\\/en\\\/1509779\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-11T17:01:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005741\\\/en\\\/1509779\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005741\\\/en\\\/1509779\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Melanoma Therapeutics Market (2022 to 2027) &#8211; Featuring AB Sciences, AbbVie and Genentech Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Melanoma Therapeutics Market (2022 to 2027) - Featuring AB Sciences, AbbVie and Genentech Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Melanoma Therapeutics Market (2022 to 2027) - Featuring AB Sciences, AbbVie and Genentech Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Melanoma Therapeutics Market (2022-2027) by Type of Melanoma, Therapy, Diagnostics, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Melanoma Therapeutics Market is estimated to be USD 12.06 Bn in 2022 and is projected to reach USD 19.79 Bn by 2027, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-11T17:01:50+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220711005741\/en\/1509779\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Melanoma Therapeutics Market (2022 to 2027) &#8211; Featuring AB Sciences, AbbVie and Genentech Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-07-11T17:01:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/"},"wordCount":752,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220711005741\/en\/1509779\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/","name":"Global Melanoma Therapeutics Market (2022 to 2027) - Featuring AB Sciences, AbbVie and Genentech Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220711005741\/en\/1509779\/21\/logo.jpg","datePublished":"2022-07-11T17:01:50+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220711005741\/en\/1509779\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220711005741\/en\/1509779\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-melanoma-therapeutics-market-2022-to-2027-featuring-ab-sciences-abbvie-and-genentech-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Melanoma Therapeutics Market (2022 to 2027) &#8211; Featuring AB Sciences, AbbVie and Genentech Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46039"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46039\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46039"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46039"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}